MTEK: financial statements from SEC

Income statement

Metric	31 Dec 2025	31 Dec 2024	31 Dec 2023	31 Dec 2022
Revenue	1M	6M	4M	3M
Cost of revenue	2M	3M	2M	2M
Gross profit	−363,749	4M	2M	782,792
Research and development	1M	927,048	1M	1M
Selling, general and administrative	2M	3M	3M	3M
Operating expenses	5M	5M	5M	4M
Operating income	−5M	−1M	−3M	−4M
Net income	−5M	−1M	−3M	−4M
Earnings per share	−0.67	−0.16	−0.34	−0.49
Earnings per share, diluted	−0.67	−0.16	−0.34	−0.49
Weighted average shares	8M	8M	8M	8M

Metric	19 Aug 2026	18 Aug 2026	31 Dec 2025	31 Dec 2024	31 Dec 2023	31 Dec 2022	31 Dec 2021
Cash and equivalents	—	—	3M	2M	2M	255,530	49,126
Short-term investments	—	—	—	—	3M	—	—
Receivables	—	—	588,949	3M	3M	—	—
Inventory	—	—	3M	3M	2M	—	—
Current assets	—	—	6M	9M	10M	—	—
Property, plant and equipment	—	—	313,772	407,430	313,649	—	—
Total assets	—	—	7M	10M	11M	—	—
Current liabilities	—	—	4M	3M	3M	—	—
Short-term debt	—	—	2M	9,345	—	—	—
Total liabilities	—	—	7M	4M	4M	—	—
Equity	—	—	601,583	6M	7M	10M	−2M
Shares outstanding	—	—	8M	8M	8M	—	—
Shares issued	—	—	8M	8M	8M	—	—
Treasury shares	—	—	120,715	120,715	120,715	—	—

Metric	31 Dec 2025	31 Dec 2024	31 Dec 2023	31 Dec 2022
Operating cash flow	−3M	−2M	−4M	−5M
Depreciation and amortisation	116,358	97,213	60,649	17,211
Share-based compensation	166,571	154,450	126,769	75,896
Capital expenditure	22,700	190,994	90,508	284,490
Investing cash flow	−22,700	3M	6M	−9M
Financing cash flow	4M	−489,436	−119,536	14M